Clarius Ultrasound Scanner
Clarius Mobile Health Corp. • Radiology • 11/15/2021
Device Purpose
The Clarius Ultrasound Scanner is a portable diagnostic imaging system utilizing wireless HD3 transducers and a mobile app to provide real-time ultrasound visualization and fluid flow analysis for a wide array of clinical applications. Its methodology relies on piezoelectric principles for image generation, wireless data transmission to standard mobile devices, and its performance and safety are substantiated through comprehensive non-clinical testing against established medical device standards.
Summary
The Clarius Ultrasound Scanner is a portable, software-controlled diagnostic ultrasound system designed to acquire and display high-resolution, real-time ultrasound data. It employs various wireless transducer models (C3 HD3, C7 HD3, EC7 HD3, L7 HD3, L15 HD3, PA HD3, L20 HD3) that utilize piezoelectric technology to generate images by transmitting high-frequency, non-ionizing sound waves and converting the echoes into electronic signals. These images are wirelessly transmitted via Wi-Fi and Bluetooth to a compatible off-the-shelf iOS or Android device running the Clarius Ultrasound App for display, supporting multiple imaging modes including B-mode, M-mode, Color Doppler, Power Doppler, and Pulse-Wave Doppler. The HD3 series of scanners feature an internal, non-removable lithium-ion battery and come with accessories like a charger and fan. This system is intended for use by qualified healthcare professionals trained in ultrasound, supporting a comprehensive range of diagnostic imaging applications such as ophthalmic, fetal, abdominal, intra-operative (non-neurological), pediatric, small organ, cephalic, trans-rectal, trans-vaginal, musculo-skeletal, urology, gynecology, cardiac, peripheral vessel, and carotid imaging, along with procedural needle guidance. Designed for use in diverse healthcare settings, including emergency medical services, the Clarius Ultrasound Scanner's HD3 models have undergone extensive non-clinical performance testing. This testing verified compliance with numerous international standards for medical electrical equipment safety, electromagnetic compatibility, usability, acoustic output, and software lifecycle processes, ensuring the device meets its specified clinical application requirements and user needs.
AI Regulatory Concerns
Powered by
Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.
Keywords
Device Metadata
Relevant Clinical Questions
- Q1. How does the image quality of the Clarius HD3 scanners compare to larger, cart-based ultrasound systems across its various indicated applications, particularly in challenging imaging scenarios like deep abdominal or cardiac exams in obese patients?; What is the typical battery life of the HD3 scanners with their internal non-removable battery during continuous use in demanding modes like Color Doppler, and what is the recharge time?; Considering its reliance on consumer-grade iOS/Android devices and Wi-Fi/Bluetooth connectivity, what specific cybersecurity measures are implemented within the Clarius Ultrasound App and transducer firmware to protect patient data and ensure system integrity, especially in networked hospital environments?; What are the specific improvements in image resolution or diagnostic capability offered by the 'HD3' generation of transducers compared to the previous 'HD' generation mentioned for the predicate device?; For procedural guidance, what is the measured accuracy and latency of the system in visualizing needles, and how does this performance vary across different tissue types and depths?
Risk Classification
ESL AnalysisFDA Class II via 510(k) pathway; IEC 62304 Class B (software safety classification); Authorized before §524B enforcement
Learn how Parasoft automates IEC 62304 compliance testing →Cybersecurity Evidence
Powered by SBOMator™Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.
Supply Chain BOM Evidence
Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.
Analysis:
• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.
• Evidence of SaaSBOM, HBOM, OBOM detected in AI-generated device summary.
• This device was authorized before §524B took effect. Cybersecurity evidence requirements were less prescriptive at the time.
• Postmarket cybersecurity monitoring plan not clearly documented in AI-generated device summary.
• Not detected in AI-generated device summary: SBOM, ML-BOM, CBOM, VDR/VEX. These may be present in the full FDA submission.
Preparing a similar submission?
ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.
Assess Your Readiness →Or contact ESL directly